Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study (2024)

First Author: Cooper L
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(23)00688-6

PubMed Identifier: 38246190

Publication URI: http://europepmc.org/abstract/MED/38246190

Type: Journal Article/Review

Parent Publication: The Lancet Infectious Diseases

ISSN: 1473-3099